Onxeo SA reported earnings results for the full year ended December 31, 2021. For the full year, the company reported revenue was EUR 4.06 million compared to EUR 1.78 million a year ago. Net loss was EUR 5.94 million compared to net income of EUR 1.09 million a year ago.

Basic loss per share from continuing operations was EUR 0.07 compared to basic earnings per share from continuing operations of EUR 0.01 a year ago. Diluted loss per share from continuing operations was EUR 0.07 compared to diluted earnings per share from continuing operations of EUR 0.01 a year ago.